ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is CK Life Sciences International (Holdings), Inc. ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0.51%
- The company is Net-Debt Free
2
Flat results in Jun 26
- OPERATING CASH FLOW(Y) Lowest at HKD -170.56 MM
- RAW MATERIAL COST(Y) Grown by 17.92% (YoY)
- CASH AND EQV(HY) Lowest at HKD 535.65 MM
3
With ROE of 1.23%, it has a Very Expensive valuation with a 1.45 Price to Book Value
- Over the past year, while the stock has generated a return of -41.40%, its profits have fallen by -60.1%
4
Below par performance in long term as well as near term
- Along with generating -41.40% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is CK Life Sciences International (Holdings), Inc. for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
CK Life Sciences International (Holdings), Inc.
-100.0%
1.30
37.82%
Hang Seng Hong Kong
-5.07%
-0.26
18.70%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
381.57%
EBIT Growth (5y)
69.38%
EBIT to Interest (avg)
0.24
Debt to EBITDA (avg)
2.62
Net Debt to Equity (avg)
1.42
Sales to Capital Employed (avg)
0.27
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.51%
ROE (avg)
1.31%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
118
Industry P/E
Price to Book Value
1.45
EV to EBIT
848.95
EV to EBITDA
126.90
EV to Capital Employed
1.18
EV to Sales
4.24
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.14%
ROE (Latest)
1.23%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
PRE-TAX PROFIT(Q)
At HKD -18.36 MM has Grown at 86.42%
NET PROFIT(Q)
At HKD -28.73 MM has Grown at 80.94%
-6What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at HKD -170.56 MM
RAW MATERIAL COST(Y)
Grown by 17.92% (YoY
CASH AND EQV(HY)
Lowest at HKD 535.65 MM
DEBT-EQUITY RATIO
(HY)
Highest at 159.51 %
Here's what is working for CK Life Sciences International (Holdings), Inc.
Pre-Tax Profit
At HKD -18.36 MM has Grown at 86.42%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Net Profit
At HKD -28.73 MM has Grown at 80.94%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
Here's what is not working for CK Life Sciences International (Holdings), Inc.
Operating Cash Flow
Lowest at HKD -170.56 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (HKD MM)
Cash and Eqv
Lowest at HKD 535.65 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at 159.51 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 17.92% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
